Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
CompletedNCT05103319
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is to retrospective investigate the effects of the simultaneous intravenous (i.v.) administration of lidocaine and ketamine on a four to six weeks interval in treatment refractory different chronic pain conditions.
Study details
- Official title
- Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions - A Retrospective Analysis
- Conditions
- Interventions
- Other: Data collection for statistical analysis to identify patterns of treatment response/ non-response
- Sponsor
- University Hospital, Basel, Switzerland
- Start date
- 2021-09-07
- Primary completion
- 2022-01-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Switzerland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ICD11 Medical diagnosis of chronic pain and its subcategories * Treatment with intravenous lidocaine and ketamine infusions during the years of 2012 to May 2021 at our pain unit at the USB * Patient is at least 18 years of age at the beginning of the first infusion treatment Exclusion Criteria: * Patient is underage at the beginning of the first infusion treatment * Documented written refusal of consent for research (general consent or specific study consent) * Patients undergoing treatment with only lidocaine or ketamine respective
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05103319